Adding 5 g / 100 g of Mycofix® Select 3.0 (M) and g / Kg of Activated Charcoal (A) to a poultry diet contaminated with aflatoxin B1 (B1) at a concentration of 0.02 μg / kg to the superiority of treatments B1AM, B1M, and B1A significantly increased the Total Weight of the broiler at 1 day and fed on a poultry diet contaminated with B1 for 21 days before slaughter with a percentage 36.9%, 34.5% and 21.5% respectively, and increased Heart weight by 23.9%, 16.6% and 6.3%, and Liver weight increased by 33.50%, 15.07% and 7.2% and increase the weight of the Craw by 25.08%, 9.3% and 11.1%.The treatments B1AM and B1A showed significantly increased the weight of Bile by 52.4% and 1.3%.Treatment B1 reduced the value of Packed Cell Volume (PCV) by 36.3% while B1MA and B1M significantly increased PCV values by 20.5 and 14.3%. Treatment B1 reduced the value of Hb by 37.07% while B1MA and B1M significantly increased Hb values by 22.07% and 14.79%. Treatment with B1 reduced Red Blood Cell (RBC) by 13.7%while B1MA, B1A and B1M significantly increased the number of RBC by 16.37%, 15.04% and 2.63%. Treatment with B1 increased the number of white blood cell (WBC) by 27.42% while B1M, B1A and B1MA significantly reduced WBC numbers by 23.44%, 21.77%, and 6.48% compared to their value in the comparison treatment (0.0). B1A, B1M and B1MA showed a significant increase in Monocyte values of 103.3%, 60.60% and 36.36% compared to B1 treatment. Treatment B1 reduced Monocyte by 46.23% compared to the comparison treatment (0.0). Treatment B1 reduced Lymphocyte values by 27.48% compared to the comparison treatment (0.0) while B1M and B1A significantly increased Lymphocyte values by 10.945% and 5.59% compared to their values in B1 treatment, The B1M treatment gave the lowest decrease in Neutrophils values of 24.87% followed by B1A treatment reduced in Neutrophils values by 18.47% compared to B1 treatment. Treatment B1 increased the value of Neutrophils by 83.7% compared to the comparison treatment (0.0). B1M showed the highest increase in Basophils values of 41.26% followed by treatment of B1A and B1MA increased by 38.09% and 34.92%. Treatment B1A showed the highest increase in Eosinophils values by 80.0%followed by treatment of B1MA and B1M by 40.0% and 20.0% compared to B1 treatment.

Download this article as